Search

Your search keyword '"Cocco E"' showing total 969 results
Start Over Author "Cocco E"
969 results on '"Cocco E"'

102. Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis

Author

Ghezzi A, Annovazzi P, Amato MP, Capello E, Cavalla P, Cocco E, Falcini M, Patti F, Perini P, Rodegher ME, Rovaris M, Rottoli MR, Comi G, MS Study Group Italian Society of Neurology, GALLO, Antonio, Ghezzi, A, Annovazzi, P, Amato, Mp, Capello, E, Cavalla, P, Cocco, E, Falcini, M, Gallo, Antonio, Patti, F, Perini, P, Rodegher, Me, Rovaris, M, Rottoli, Mr, Comi, G, MS Study Group Italian Society of, Neurology, Gallo, A, and Comi, Giancarlo

Subjects
Adult, Male, medicine.medical_specialty, Multiple Sclerosis, Status epilepticus, Aspiration pneumonia, Internal medicine, medicine, Humans, Myocardial infarction, Adverse effect, Stroke, business.industry, Multiple sclerosis, Endovascular Procedures, Brain, medicine.disease, Thrombosis, Hydrocephalus, Surgery, Spinal Cord, Venous Insufficiency, Neurology, Cardiology, Female, Neurology (clinical), medicine.symptom, business
Abstract

Although it is debated whether chronic cerebro-spinal venous insufficiency (CCSVI) plays a role in multiple sclerosis (MS) development, many patients undergo endovascular treatment (ET) of CCSVI. A study is ongoing in Italy to evaluate the clinical outcome of ET. Severe adverse events (AEs) occurred in 15/462 subjects at a variable interval after ET: jugular thrombosis in seven patients, tetraventricular hydrocephalus, stroke, paroxysmal atrial fibrillation, status epilepticus, aspiration pneumonia, hypertension with tachicardia, or bleeding of bedsore in the remaining seven cases. One patient died because of myocardial infarction 10 weeks after ET. The risk of severe AEs related to ET for CCSVI must be carefully considered.

Published
2013

103. TORRE DEL CERRANO E NATURA 2000

Author

Vallarola, F., Cargini, D., De Ascentiis, A., Di Giandomenico, M., Zollo, A., Aretusi, G., Crocetti, C., Casareale, C., D'Andrea, R., Lombardi, A., Di Meo, C., Iachini, A., Tiscar, Pietro Giorgio, Pedicini, Silvia, Ferrara, Ermete, Gadaleta, F., DI FRANCESCO, Cristina Esmeralda, Mosca, Francesco, Mercurio, M., Cardone, F., Corriero, G., Piccirilli, R., DI GUARDO, Giovanni, Profeta, Francesca, Chiodo, E., De Nicola, M., Dimplflmeier, F., Cocco, E., Sabatino, P., Cerrano, C., Di Camillo, C. G., Pica, D., Torsani, F., Bastari, A., Corti, G., Cocco, S., Cardelli, V., Borguete Alves, R. R., Agnelli, A., and Fornasier, F.

Published
2015

105. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

Author

Martinelli V, Cocco E, Capra R, Salemi G, Gallo P, Capobianco M, Pesci I, Ghezzi A, Pozzilli C, Lugaresi A, Bellantonio P, Amato MP, Grimaldi LM, Trojano M, Mancardi GL, Bergamaschi R, Gasperini C, Rodegher M, Straffi L, Ponzio M, Comi G, Italian Mitoxantrone G.r.o.u.p. COLLABORATORS: Radaelli M, Esposito F, Moiola L, Colombo B, Rossi P, Marrosu MG, Frau J, Lorefice L, Coghe G, Savettieri G, Ragonese P, Cusimano V, Perini P, Rinaldi F, Vidali A, Bertolotto A, Malucchi S, Di Sapio A, Montanari E, Guareschi A, Rizzo A, Zaffaroni M, Baldini S, De Rossi N, Cordioli C, Rasia S, Salvetti M, Buttinelli C, Ausili Cefaro L, De Luca G, Tommaso D, Farina D, Fantozzi R, Ruggieri S, Hakiki B, Zipoli V, Portaccio E, Bartolozzi ML, Scandellari C, Stecchi S, Marchello LP, Palmeri B, Vitello G, Iaffaldano P, Lucchese G, Dattola V, Buccafusca M, Sola P, Simone AM, Barreca F, Patti F, Laisa P, Cavalla P, Masera S, Tavazzi E, Galgani S, Sacco R, Provinciali L, Maura D, LUS, Giacomo, Alfieri G, Ticca A, Piras ML, Maimone D, Bianca M, Iudice A, Giro ME, Galeotti M, Florio C, Spitalieri P, La Mantia L, Motti L, Rottoli MR, Granella F, Solaro C, Scarpini E, Servillo G, Cavalletti G., TEDESCHI, Gioacchino, Martinelli, V, Cocco, E, Capra, R, Salemi, G, Gallo, P, Capobianco, M, Pesci, I, Ghezzi, A, Pozzilli, C, Lugaresi, A, Bellantonio, P, Amato, Mp, Grimaldi, Lm, Trojano, M, Mancardi, Gl, Bergamaschi, R, Gasperini, C, Rodegher, M, Straffi, L, Ponzio, M, Comi, G, COLLABORATORS: Radaelli M, Italian Mitoxantrone G. r. o. u. p., Esposito, F, Moiola, L, Colombo, B, Rossi, P, Marrosu, Mg, Frau, J, Lorefice, L, Coghe, G, Savettieri, G, Ragonese, P, Cusimano, V, Perini, P, Rinaldi, F, Vidali, A, Bertolotto, A, Malucchi, S, Di Sapio, A, Montanari, E, Guareschi, A, Rizzo, A, Zaffaroni, M, Baldini, S, De Rossi, N, Cordioli, C, Rasia, S, Salvetti, M, Buttinelli, C, Ausili Cefaro, L, De Luca, G, Tommaso, D, Farina, D, Fantozzi, R, Ruggieri, S, Hakiki, B, Zipoli, V, Portaccio, E, Bartolozzi, Ml, Scandellari, C, Stecchi, S, Marchello, Lp, Palmeri, B, Vitello, G, Iaffaldano, P, Lucchese, G, Dattola, V, Buccafusca, M, Sola, P, Simone, Am, Barreca, F, Patti, F, Laisa, P, Cavalla, P, Masera, S, Tavazzi, E, Galgani, S, Tedeschi, Gioacchino, Sacco, R, Provinciali, L, Maura, D, Lus, Giacomo, Alfieri, G, Ticca, A, Piras, Ml, Maimone, D, Bianca, M, Iudice, A, Giro, Me, Galeotti, M, Florio, C, Spitalieri, P, La Mantia, L, Motti, L, Rottoli, Mr, Granella, F, Solaro, C, Scarpini, E, Servillo, G, and Cavalletti, G.

Published
2011

106. Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin

Author

Carboni, N, Brancati, F, Cocco, E, Solla, E, D'Apice, M, Mateddu, A, Mcintyre, A, Fadda, E, Mura, M, Lattanzi, G, Piras, R, Maioli, M, Marrosu, G, Novelli, G, Marrosu, M, and Hegele, R

Subjects
Male, Lipodystrophy, Physiology, Siblings, Karyotype, Comorbidity, Middle Aged, Muscular Dystrophies, Body Fat Distribution, Female, Humans, Neurology (clinical), Cellular and Molecular Neuroscience, Physiology (medical), Settore MED/03 - Genetica Medica
Published
2014

108. Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study)

Author

Lanzillo, R., Quarantelli, M., Veria, V., Orefice, G., Marrosu, M. G., Trojano, M., Amato, M. P., Francia, A. M., Florio, C., Tedeschi, G., Bellantonio, P., Annunziata, P., Comerci, M., Brunetti, A., Bonavita, V., Alfano, B., Marini, S., Pozzilli, C., Brescia Morra, V, Schiavone, V, Vacchiano, V., Vacca, G., Cocco, E., Sosso, L., Patti, F., Stecchi, Provinciali, Sinisi, L., Ardito, B., Maimone, D., Zorzon, M., Grimaldi, L. M., Carolei, A., Costantino, G., Protti, A., Bianconi, C., Bertolotto, A., Motti, L., Meola, G., Sacco, R., and Maniscalco, G.

Subjects
Multiple Sclerosis, MRI
Published
2014

109. Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study

Author

Cocco, E, Sardu, C, Gallo, P, Capra, R, Amato, Mp, Trojano, M, Uccelli, A, Marrosu, Mg, Galeotti, M, Cordioli, C, Massole, S, Musu, L, Coghe, G, Patti, Francesco, Lugaresi, A, Tola, Mr, Zipoli, V, Mancardi, Gl, Capello, E, Solaro, C, Caputo, C, Cavarretta, R, Merelli, E, Perini, P, Francia, A, Batocchi, Ap, Ergamaschi, R, Tavazzi, E, Cavalla, P, Masera, S, Bertolotto, A, Capobianco, M, Zorzon, M, Ghezzi, A, Zaffaroni, M., COCCO E, SARDU C, GALLO P, CAPRA R, AMATO MP, TROJANO M, UCCELLI A, MARROSU MG, THE FEMIMS GROUP, and A. LUGARESI

Subjects
Adult, Male, Questionnaires, medicine.medical_specialty, Multiple Sclerosis, media_common.quotation_subject, Fertility, Young Adult, Risk Factors, Internal medicine, medicine, Humans, Risk factor, Young adult, Amenorrhea, media_common, Retrospective Studies, Menarche, Mitoxantrone, Cumulative dose, business.industry, Retrospective cohort study, medicine.disease, multiple sclerosis, mitoxantrone, treatment, amenorrhea, drug therapy/epidemiology, Menopause, Settore MED/26 - NEUROLOGIA, Endocrinology, Neurology, Adult, Amenorrhea, chemically induced/epidemiology, Female, Follow-Up Studies, Humans, Immunosuppressive Agents, adverse effects, Infertility, Female, chemically induced/epidemiology, Male, Menarche, Menopause, Mitoxantrone, adverse effects, Multiple Sclerosis, drug therapy/epidemiology, Questionnaires, Retrospective Studies, Risk Factors, Young Adult, Infertility, adverse effects, chemically induced/epidemiology, Neurology (clinical), medicine.symptom, business, Infertility, Female, Immunosuppressive Agents, medicine.drug, Follow-Up Studies
Abstract

Background Improved prognosis in women with multiple sclerosis (MS) undergoing immunosuppressive treatment with mitoxantrone (MITO) has led to an increased interest in the effect of such treatments on fertility. FErtility and Mitoxantrone In MS (FEMIMS) is a collaborative retrospective study aimed at evaluating the impact of MITO treatment on fertility in women with MS. Methods Occurrence of chemotherapy-induced amenorrhea (CIA) was evaluated in 189 women with MS treated with MITO before the age of 45. An “ad hoc” questionnaire, paying particular attention to onset of CIA either during or post-MITO treatment, was administered to each patient. The probability of CIA was calculated using a multivariate logistic regression analysis taking into account age at exposure, cumulative dose, and use of estroprogestinic (EP) drugs during treatment. Results Forty-eight (26%) patients presented CIA following MITO. The probability of CIA was increased by 2%/mg/m2 of cumulative dose and by 18% for each year of age, whereas it was reduced by administration of EP during treatment. Conclusions MITO treatment may affect reproductive capacity in women with MS. Patients of childbearing age should be properly counseled before MITO treatment and EP therapy should be administered to reduce the risk of CIA.

Published
2008

115. Oral Bacterial Activity is Significantly Associated with Autoimmune Liver Diseases and it Could be Involved in their Pathogenesis Mechanisms

Author

Figorilli, F., primary, Orrù, G., additional, Onali, S., additional, Salustro, C., additional, Cappellini, S., additional, Cocco, E., additional, Fais, S., additional, Melis, M., additional, Gilardi, A., additional, Secci, L., additional, Casu, S., additional, Littera, S., additional, and Chessa, L., additional

Published
2016
Full Text
View/download PDF

116. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis

Author

Capello E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, Marmont A, Uccelli A, Inglese M, Bruzzi P, Sormani MP, Cocco E, Meucci G, Massacesi L, Bertolotto A, Lugaresi A, Merelli E, Solari A, Filippi M, Mancardi GL, Italian GITMO-Neuro Intergroup on ASCT for Multiple Sclerosis, La Nasa G, Marrosu MG, Derchi V, Di Bartolomeo P, Farina D, Iarlori C, Tartaro A, Repice A, Pellicanò G, Dogliotti L, Parodi RC, Schenone A, Donelli A, Casoni F, Cavalleri F, Capobianco M, Guerrasio A, Duca S, Papineschi F, Scappini B, Mosti S, Abbruzzese A, Capello, E, Saccardi, R, Murialdo, A, Gualandi, F, Pagliai, F, Bacigalupo, A, Marmont, A, Uccelli, A, Inglese, M, Bruzzi, P, Sormani, Mp, Cocco, E, Meucci, G, Massacesi, L, Bertolotto, A, Lugaresi, A, Merelli, E, Solari, A, Filippi, M, Mancardi, Gl, Italian GITMO-Neuro Intergroup on ASCT for Multiple, Sclerosi, La Nasa, G, Marrosu, Mg, Derchi, V, Di Bartolomeo, P, Farina, D, Iarlori, C, Tartaro, A, Repice, A, Pellicanò, G, Dogliotti, L, Parodi, Rc, Schenone, A, Donelli, A, Casoni, F, Cavalleri, F, Capobianco, M, Guerrasio, A, Duca, S, Papineschi, F, Scappini, B, Mosti, S, and Abbruzzese, A

Subjects
Oncology, Adult, medicine.medical_specialty, Multiple Sclerosis, medicine.medical_treatment, Inflammation, Dermatology, Transplantation, Autologous, Severity of Illness Index, methods, Autologous stem-cell transplantation, Internal medicine, medicine, Humans, Severe disability, Salvage Therapy, Transplantation, Adult, Hematopoietic Stem Cell Transplantation, methods, Humans, Immunosuppressive Agents, therapeutic use, Italy, Magnetic Resonance Imaging, Multiple Sclerosis, diagnosis/immunology/therapy, Salvage Therapy, Severity of Illness Index, Transplantation, Autologous, Treatment Outcome, business.industry, Multiple sclerosis, Hematopoietic Stem Cell Transplantation, diagnosis/immunology/therapy, Immunosuppression, General Medicine, medicine.disease, Magnetic Resonance Imaging, Psychiatry and Mental health, Haematopoiesis, Treatment Outcome, Italy, therapeutic use, Neurology (clinical), medicine.symptom, Stem cell, business, Autologous, Immunosuppressive Agents
Abstract

Aggressive forms of multiple sclerosis (MS) represent a limited group of demyelinating diseases that rapidly progress to severe disability. Currently available therapies are poorly effective against these clinical entities. Recently, it has been demonstrated that intense immunosuppression followed by autologous haematopoietic stem cell transplantation (AHSCT) can affect the clinical course of individuals with severe MS and completely abrogate the inflammatory activity detected by MRI. We report the result of the Italian phase 2 GITMO study, a multicentre study in which 21 MS patients, who were rapidly deteriorating and not responding to the usual therapeutic strategies, were treated with this procedure. The clinical effect of the treatment is long lasting, with a striking abrogation of inflammation detected by MRI findings. These results support a role for intense immunosuppression followed by ASCT as treatment in rapidly evolving MS cases unresponsive to conventional therapies.

Published
2005

118. Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD

Author

Zhao, S, Choi, M, Overton, Jd, Bellone, S, Roque, Dm, Cocco, E, Guzzo, F, English, Dp, Varughese, J, Gasparrini, S, Bortolomai, I, Buza, N, Hui, P, Abu Khalaf, M, Ravaggi, Antonella, Bignotti, Eliana, Bandiera, Elisabetta, Romani, Chiara, Todeschini, Paola, Tassi, R, Zanotti, Laura, Carrara, L, Pecorelli, Sergio, Silasi, Da, Ratner, E, Azodi, M, Schwartz, Pe, Rutherford, Tj, Stiegler, Al, Mane, S, Boggon, Tj, Schlessinger, J, Lifton, Rp, and Santin, Ad

Published
2013

119. Clinical activity after fingolimod cessation: disease reactivation or rebound?

Author

Frau, J., Sormani, M. P., Signori, A., Realmuto, S., Baroncini, D., Annovazzi, P., Signoriello, E., Maniscalco, G. T., La Gioia, S., Cordioli, C., Frigeni, B., Rasia, S., Fenu, G., Grasso, R., Sartori, A., Lanzillo, R., Stromillo, M. L., Rossi, S., Forci, B., and Cocco, E.

Subjects
FINGOLIMOD, MULTIPLE sclerosis treatment, DISEASE relapse, DRUG side effects, PUBLIC health
Abstract

Background and purpose: There is debate as to whether the apparent rebound after fingolimod discontinuation is related to the discontinuation itself or whether it is due to the natural course of highly active multiple sclerosis (MS). Our aim was to survey the prevalence of severe reactivation and rebound after discontinuation of fingolimod in a cohort of Italian patients with MS. Methods: Patients with relapsing–remitting MS who were treated with fingolimod for at least 6 months and who stopped treatment for reasons that were unrelated to inefficacy were included in the analysis. Results: A total of 100 patients who had discontinued fingolimod were included in the study. Fourteen patients (14%) had a relapse within 3 months after fingolimod discontinuation, and an additional 12 (12%) had a relapse within 6 months. According to this study's criteria, 10 patients (10%) had a severe reactivation. Amongst these patients, five (5%) had a reactivation that was considered to be a rebound. Conclusions: The present study showed that more than 26% of patients are at risk of having a relapse within 6 months after fingolimod discontinuation. Nevertheless, the risk of severe reactivations and rebound is lower than has been previously described. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

120. Cerebrospinal fluid findings in Devic?s neuromyelitis optica

Author

Zaffaroni, M, Trojano, M, Paolicelli, D, Capra, R, Salvi, F, Pastorelli, F, Marrosu, G, Cocco, E, Patti, Francesco, Tola, R, Caniatti, L, Amato, Mp, Ghezzi, A, Mancardi, Gl, Murialdo, A, Roccatagliata, L, Milanese, C, La Mantia, L, Comi, G, Martinelli, V, Filippi, M, Merelli, E, Sola, P, Bergamaschi, R, Tonietti, S, Gallo, P, Perini, P, and Bertolotto, A.

Subjects
Adult, Male, medicine.medical_specialty, Pathology, Neurology, Adolescent, Immunoglobulins, Lymphocytosis, Dermatology, Spinal Puncture, Diagnosis, Differential, White matter, Cerebrospinal fluid, medicine, Humans, Child, Pleocytosis, Aged, Neuromyelitis optica, medicine.diagnostic_test, business.industry, Lumbar puncture, Multiple sclerosis, Neuromyelitis Optica, General Medicine, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Psychiatry and Mental health, medicine.anatomical_structure, Child, Preschool, Female, Neurology (clinical), Differential diagnosis, business
Abstract

Relapsing Devic's neuromyelitis optica (DNO) may be clinically undistinguishable from multiple sclerosis (MS), thus the differential diagnosis relies mainly on neuroimaging and cerebrospinal fluid (CSF) findings. We studied CSF samples from 44 patients with DNO submitted to at least one lumbar puncture. Pleocytosis, IgG synthesis and blood brain barrier damage were the most frequent abnormalities, pleocytosis being very suggestive of DNO in patients fulfilling clinical and MRI diagnostic criteria. Pleocytosis > or =50 cells/mm3 is more frequent in the active phases of the disease. Oligoclonal bands (OBs) should be re-considered within the diagnostic criteria of DNO for possible variations in time: at variance with MS they may also disappear. Thus, more than one CSF examination should be done in the presence of suspected DNO, preferably in different disease phases. Although uncommon, OBs do not exclude DNO if optic nerve and spinal cord are the only sites of white matter damage, provided that cerebral MRI is normal at onset and during follow up.

Published
2004
Full Text
View/download PDF

121. T Regulatories (Tregs) and suppressor cytokine mRNA (IL-10, TGF-beta, IL-27) increase after Alemtuzumab in MS: First 25 Month Immunological Report on 323 and 324 Genzyme trials

Author

DE MERCANTI, STEFANIA FEDERICA, Cucci, Marie Angele, Viglietti, E, Giai Via, A, Taverna, Daniela, Cimino, D, Rolla, Simona, Bardina, Valentina, Novelli, Francesco, Vargas, J, Gibbin, M, Piazza, F, Vladic, A, B. r. i. n. a. V., Habek, M, Cocco, E, Annavazzi, P, Horakova, D, Kovarova, I, Clerico, Marinella, and Durelli, Luca

Published
2012

122. Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials

Author

DE MERCANTI, STEFANIA FEDERICA, Cucci, Marie Angele, Viglietti, E, Giai Via, A, Taverna, Daniela, Cimino, D, Rolla, Simona, Bardina, Valentina, Novelli, Francesco, Vargas, J, Gibbin, M, Piazza, F, Vladic, A, B. r. i. n. a. V., Habek, M, Cocco, E, Annavazzi, P, Horakova, D, Clerico, Marinella, and Durelli, Luca

Published
2012

123. Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of an Italian cohort of 462 cases

Author

Ghezzi, A., Annovazzi, P. O., Amato, M. P., Balgera, R., Banfi, P., Bartolozzi, M. L., Bergamaschi, R., Bertolotto, A., Bianchi, A., Bosco, A., Capello, E., Capobianco, M., Capra, R., Cavalla, P., Clerici, R., Coarelli, Giulia, Cocco, E., De Rossi, N., Tillio Di, C., Ferro, M. T., Gallo, A., Gallo, P., Lamantia, L., Lugaresi, A., Lus, G., Malucchi, S., Moiola, L., Provinciali, L., Patti, F., Perini, P., Perrone, P., Protti, A., Rodegher, M. E., Rossi, P., Rottoli, M., Rovaris, M., Salemi, G., Salvetti, Marco, Simone, I., Tola, M. R., Trojano, M., Vitetta, F., Marrosu, M. G., Comi, G., Study Group, M. S., Neurology, Italian Society O. F., and Italian Society Ofneurology

Published
2012

124. PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

Author

Black, J.D., primary, Lopez, S., additional, Cocco, E., additional, Bellone, S., additional, Altwerger, G., additional, Schwab, C.L., additional, English, D.P., additional, Bonazzoli, E., additional, Predolini, F., additional, Ferrari, F., additional, Ratner, E., additional, Silasi, D.A., additional, Azodi, M., additional, Schwartz, P.E., additional, and Santin, A.D., additional

Published
2015
Full Text
View/download PDF

125. Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo

Author

Schwab, C.L., primary, English, D.P., additional, Black, J., additional, Bellone, S., additional, Lopez, S., additional, Cocco, E., additional, Bonazzoli, E., additional, Bussi, B., additional, Predolini, F., additional, Ratner, E., additional, Silasi, D., additional, Azodi, M., additional, Rutherford, T.J., additional, Schwartz, P.E., additional, and Santin, A.D., additional

Published
2015
Full Text
View/download PDF

126. Disease re-activation during pregnancy after natalizumab suspension in patients with multiple sclerosis

Author

Amato, M., primary, Tortorella, C., additional, Trojano, M., additional, Cocco, E., additional, Marrosu, M.G., additional, Lugaresi, A., additional, Annovazzi, P., additional, Ghezzi, A., additional, Gasperini, C., additional, Iudice, A., additional, Bellantonio, P., additional, Patti, F., additional, Cavalla, P., additional, Totaro, R., additional, Pozzilli, C., additional, Bosco, A., additional, Uccelli, A., additional, Lanzillo, R., additional, Brescia Morra, V., additional, Portaccio, E., additional, and for, T.H.E., additional

Published
2015
Full Text
View/download PDF

129. Oral bacterial load in autoimmune liver diseases: possible role or coincidence?

Author

Orrù, G., primary, Onali, S., additional, Salustro, C., additional, Cappellini, S., additional, Cocco, E., additional, Fais, S., additional, Melis, M., additional, Gilardi, A., additional, Musu, B., additional, Secci, L., additional, Serra, G., additional, Balestrieri, C., additional, Conti, M., additional, Casale, M., additional, Casu, S., additional, Figorilli, F., additional, Pasetto, M.C., additional, Littera, R., additional, Scioscia, R., additional, Barca, L., additional, and Chessa, L., additional

Published
2015
Full Text
View/download PDF

130. Harmonized European human biomonitoring in small countries: Challenges, opportunities and lessons learned in Cyprus and Luxembourg from the DEMOCOPHES study

Author

Katsonouri, A., primary, Fischer, M.E., additional, Hadjipanayis, A., additional, Arendt, M., additional, Lavranos, G., additional, Hoffmann, L., additional, Maurer-Chronakis, K., additional, Guignard, C., additional, Fragopoulou, C., additional, Cocco, E., additional, Anastasi, E., additional, Pilavakis, D., additional, Efstathiou, E., additional, Demetriou, L., additional, Hadjiefthychiou, A., additional, Demetriou, E., additional, Aerts, D., additional, Casteleyn, L., additional, Biot, P., additional, Kolossa-Gehrin, M., additional, Den Hond, E., additional, Schoeters, G., additional, Castaño, A., additional, Esteban, M., additional, Fiddicke, U., additional, Exley, K., additional, Sepai, O., additional, and Gutleb, A.C., additional

Published
2015
Full Text
View/download PDF

132. Spaces and times of the adriatic multi-city

Author

Cocco, E., Girardot, Jean-Jacques, UNISA-OER, Italy, and UNISA, Italy

Subjects
[SHS.HISPHILSO]Humanities and Social Sciences/History, Philosophy and Sociology of Sciences, [SHS.HISPHILSO] Humanities and Social Sciences/History, Philosophy and Sociology of Sciences, Intelligence territoriale
Abstract

à paraitre.; International audience

Published
2010

136. Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines

Author

Bellone, S, El Sahwi, K, Cocco, E, Casagrande, F, Cargnelutti, M, Palmieri, M, Bignotti, E, Romani, C, Silasi, Da, Azodi, M, Schwartz, Pe, Rutherford, Tj, Pecorelli, Sergio, and Santin, A. D.

Published
2009

137. Application of the Portulano method to a case of evaluation of environmental and urban development impact, Gaona Ave., Ramos Mejía, Argentina

Author

Cocco, E., Girardot, Jean-Jacques, Università degli Studi di Salerno (UNISA), UNIROMA1, and UNISA, Italy

Subjects
[SHS.HISPHILSO]Humanities and Social Sciences/History, Philosophy and Sociology of Sciences, Territorial Intelligence, [SHS.ANTHRO-SE] Humanities and Social Sciences/Social Anthropology and ethnology, Intelligence Territoriale, [SHS.ANTHRO-SE]Humanities and Social Sciences/Social Anthropology and ethnology, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2009

146. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study

Author

Roccatagliata, L, Rocca, M, Valsasina, P, Bonzano, L, Sormani, M., Saccardi, R, Mancardi, G, Filippi, M, Marrosu, Mg, La Nasa, G, Cocco, E, Cherchi, V, Lugaresi, A, Di Bartolomeo, P, Farina, D, Ialori, C, Tartaro, A, Massacesi, L, Pagliai, F, Bosi, A, Repice, A, Konze, A, Sardanelli, F, Capello, E, Murialdo, A, Gualandi, F, Parodi, Rc, Dogliotti, L, Marmont, A, Inglese, M, Comi, G, Donelli, A, Merelli, E, Casoni, F, Cavalleri, F, Bertolotto, A, Guerrasio, A, Capobianco, M, Duca, S, Meucci, G, Papineschi, F, Mosti, S, and Abruzzese, A

Published
2007

147. Lo stato dei litorali italiani

Author

Pietro, P. C., Aucelli, P, Aminti, P. L., Amore, C, Artom, C, Bellotti, P, Bozzano, A, Caputo, C, Castelliti, G, Cipriani, L. E., Cocco, E, Corradi, N, D'Alessandro, L, Damiani, L, Davoli, L, DE PIPPO, T, Devoti, S, DI GREGORIO, F, Evangelista, S, Ferrari, M, Ferri, S, Fierro, G, Fontolan, G, Ginesu, S, Giuffrida, E, Iannantuono, E, Iuliano, S, LA MONICA, G. B., Landini, B, Masciuoli, F, Nesci, O, Palmentola, G, Pranzini, E, Pugliese, F, Randazzo, Giovanni, Raffi, R, Rosskopf, C. M., Salvatore, M. C., Silenzi, S, Simeoni, U, and Veltri, P.

Subjects
Evoluzione fascia costiera, Erosione costiera
Published
2006

149. Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study

Author

Ristori, G, Cannoni, S, Stazi, Ma, Vanacore, N, Cotichini, R, Alfo, M, Pugliatti, M, Sotgiu, S, Solaro, C, Bomprezzi, R, Di Giovanni, S, Talamanca, Lf, Nistico, L, Fagnani, C, Neale, Mc, Cascino, I, Giorgi, G, Battaglia, Ma, Buttinelli, C, Tosi, R, Salvetti, M, Italian Study Group on Multiple Sclerosis in Twins Melato, M., Dellantonio, R, Sironi, L, Bottacchi, E, Signorino, M, Angeloni, R, Curatola, R, Paci C, C., Ragno, M, Sirocchi, G, Vurchio, Am, Duc, E, Spitaleri, D, Trojano, M, Liguori, M, Cimini, G. Moretto, Porta, M., Rottoli, M. R., Mamoli, A., Camer lingo, M., Nardozza, E., Sacquegna, T., Stecchi, S., Scandellari, C., Callea, L., Capra, R., Codella, M., Marrosu, M. G., Cocco, E., Spissu, A., Cossu, G., Tronci, S., Di Lauro, A., Lombardi, E., Reggio, A., Patti, F., Valentino, P., Quattrone, A., Dfarina, D. Farina, Nives, M. E., Lugaresi, A., Perla, F., Mgrosso, M. G. Rosso, Tola, M. R., Granieri, E., Pamato, M. P. Amato, Massacesi, L., Millefiorini, E., Durastanti, V., Mancardi, G. L., Murialdo, A., Nrpizio, N. R. Pizio, Bellantonio, P., Fantozzi, R., Totaro, R., Carolei, A., Giramma, F., Lazzaro, A. T., Giraldi, C., Mazzoni, M., Giuliani, G., Pucci, E., Previdi, P., Mcfazio, M. C. Fazio, Buccafusca, M., Girlanda, P., Cmessina, C. Messina, Gd’Aleo, G. D’Aleo, Milanese, C., La Mantia, L., Caputo, D., Scarpini, E., Clerici, R., Moiola, L., Gironi, M., Merelli, E., Casoni, F., Bonavita, S., Tedeschi, G., Mleone, M. Leone, Mittino, D., Murgia, S. B., Musu, L., Gallo, P., Perini, P., Frasson, E., Salemi, G., Cuccia, G., Montanari, E., Lmanneschi, L. Manneschi, Saviola, D., Antonelli, M., Cosi, V., Rbergamaschi, R. Bergamaschi, Gallai, V., Murasecco, D., Sarchielli, P., Urcioli, R., Perticoni, G., Meucci, G., Moscato, G., Lucci, E. Covezzi, Coniglio, M. G., Dacquistapace, D. Acquistapace, Motti, L., Dossi Curro, B., Frontoni, M., Mainero, C., Giannetti, P., Pestalozza, I., Di Legge, S., Spadaro, M., Pozzilli, C., Romano, S., Mercuri, B., Scoppetta, C., Gasperini, C., Sgalgani, S. Galgani, Ggrasso, M. G. Grasso, Paolucci, S., Tonali, P. A., Leonardi, A., Oneto, A., Rosati, G., Sotgiu, M. A., Bertolotto, A., Capobianco, M., Durelli, Luca, Clerico, Marinella, Sosso, L., Bongioanni, R., Orrico, D., Carbonin, C., Freo, U., Zaffaroni, M., Ghezzi, A., and Falcone, N.

Published
2006

150. Lo stato dei litorali italiani

Author

Augelli, P. C., Aminti, P. L., Amore, C, Artom, C, Bellotti, P, Bozzano, A, Caputo, C, Castelliti, G, Cipriani, L. E., Cocco, E, Corradi, N, D'Alessandro, L, Damiani, L, Davoli, L, DE PIPPO, T, Devoti, S, DI GREGORIO, F, Evangelista, S, Ferrari, M, Ferri, S, Fierro, G, Fontolan, G, Ginesu, S, Giuffrida, E, Iannantuono, E, Iuliano, S, LA MONICA, G. B., Landini, B, Mascioli, F, Nesci, O, Palmentola, G, ENZO PRANZINI, E, Pugliese, F, Randazzo, G, Raffi, R, Rosskopf, C. M., Salvatore, MARIA CRISTINA, Silenzi, S, Simeoni, U, and Veltri, P.

Subjects
erosion rate, coastal environment, monitoring, Italy, erosione, Gestione della fascia costiera, Dinamica dei litorali, monitoraggio, Italia
Published
2006

Catalog

Books, media, physical & digital resources
See catalog results